Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Deformation-based atrophy computation by surface propagation and its application to Alzheimer's disease.

Pai A, Sporring J, Darkner S, Dam EB, Lillholm M, Jørgensen D, Oh J, Chen G, Suhy J, Sørensen L, Nielsen M.

J Med Imaging (Bellingham). 2016 Jan;3(1):014005. doi: 10.1117/1.JMI.3.1.014005. Epub 2016 Mar 16.

PMID:
27014717
2.

Statistical image analysis of longitudinal RAVENS images.

Lee S, Zipunnikov V, Reich DS, Pham DL.

Front Neurosci. 2015 Oct 20;9:368. doi: 10.3389/fnins.2015.00368. eCollection 2015.

3.

A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease.

Turner RS, Thomas RG, Craft S, van Dyck CH, Mintzer J, Reynolds BA, Brewer JB, Rissman RA, Raman R, Aisen PS; Alzheimer's Disease Cooperative Study.

Neurology. 2015 Oct 20;85(16):1383-91. doi: 10.1212/WNL.0000000000002035. Epub 2015 Sep 11.

4.

Spatio-Temporal Regularization for Longitudinal Registration to Subject-Specific 3d Template.

Guizard N, Fonov VS, García-Lorenzo D, Nakamura K, Aubert-Broche B, Collins DL.

PLoS One. 2015 Aug 24;10(8):e0133352. doi: 10.1371/journal.pone.0133352. eCollection 2015.

5.

Assessing atrophy measurement techniques in dementia: Results from the MIRIAD atrophy challenge.

Cash DM, Frost C, Iheme LO, Ünay D, Kandemir M, Fripp J, Salvado O, Bourgeat P, Reuter M, Fischl B, Lorenzi M, Frisoni GB, Pennec X, Pierson RK, Gunter JL, Senjem ML, Jack CR Jr, Guizard N, Fonov VS, Collins DL, Modat M, Cardoso MJ, Leung KK, Wang H, Das SR, Yushkevich PA, Malone IB, Fox NC, Schott JM, Ourselin S.

Neuroimage. 2015 Dec;123:149-64. doi: 10.1016/j.neuroimage.2015.07.087. Epub 2015 Aug 11.

6.

Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2.

Jack CR Jr, Barnes J, Bernstein MA, Borowski BJ, Brewer J, Clegg S, Dale AM, Carmichael O, Ching C, DeCarli C, Desikan RS, Fennema-Notestine C, Fjell AM, Fletcher E, Fox NC, Gunter J, Gutman BA, Holland D, Hua X, Insel P, Kantarci K, Killiany RJ, Krueger G, Leung KK, Mackin S, Maillard P, Malone IB, Mattsson N, McEvoy L, Modat M, Mueller S, Nosheny R, Ourselin S, Schuff N, Senjem ML, Simonson A, Thompson PM, Rettmann D, Vemuri P, Walhovd K, Zhao Y, Zuk S, Weiner M.

Alzheimers Dement. 2015 Jul;11(7):740-56. doi: 10.1016/j.jalz.2015.05.002.

7.

Estimating anatomical trajectories with Bayesian mixed-effects modeling.

Ziegler G, Penny WD, Ridgway GR, Ourselin S, Friston KJ; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2015 Nov 1;121:51-68. doi: 10.1016/j.neuroimage.2015.06.094. Epub 2015 Jul 17.

8.

The Pediatric Imaging, Neurocognition, and Genetics (PING) Data Repository.

Jernigan TL, Brown TT, Hagler DJ Jr, Akshoomoff N, Bartsch H, Newman E, Thompson WK, Bloss CS, Murray SS, Schork N, Kennedy DN, Kuperman JM, McCabe C, Chung Y, Libiger O, Maddox M, Casey BJ, Chang L, Ernst TM, Frazier JA, Gruen JR, Sowell ER, Kenet T, Kaufmann WE, Mostofsky S, Amaral DG, Dale AM; Pediatric Imaging, Neurocognition and Genetics Study.

Neuroimage. 2016 Jan 1;124(Pt B):1149-54. doi: 10.1016/j.neuroimage.2015.04.057. Epub 2015 May 1.

PMID:
25937488
9.

Effects of ECT in treatment of depression: study protocol for a prospective neuroradiological study of acute and longitudinal effects on brain structure and function.

Oltedal L, Kessler U, Ersland L, Grüner R, Andreassen OA, Haavik J, Hoff PI, Hammar Å, Dale AM, Hugdahl K, Oedegaard KJ.

BMC Psychiatry. 2015 May 1;15:94. doi: 10.1186/s12888-015-0477-y.

10.

The diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease.

Tang X, Holland D, Dale AM, Younes L, Miller MI; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2015 Jun;36(6):2093-117. doi: 10.1002/hbm.22758. Epub 2015 Feb 3.

11.

Effects of changing from non-accelerated to accelerated MRI for follow-up in brain atrophy measurement.

Leung KK, Malone IM, Ourselin S, Gunter JL, Bernstein MA, Thompson PM, Jack CR Jr, Weiner MW, Fox NC; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2015 Feb 15;107:46-53. doi: 10.1016/j.neuroimage.2014.11.049. Epub 2014 Dec 4.

12.
13.

Measuring brain atrophy with a generalized formulation of the boundary shift integral.

Prados F, Cardoso MJ, Leung KK, Cash DM, Modat M, Fox NC, Wheeler-Kingshott CA, Ourselin S; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2015 Jan;36 Suppl 1:S81-90. doi: 10.1016/j.neurobiolaging.2014.04.035. Epub 2014 Aug 29.

14.

Empowering imaging biomarkers of Alzheimer's disease.

Gutman BA, Wang Y, Yanovsky I, Hua X, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2015 Jan;36 Suppl 1:S69-80. doi: 10.1016/j.neurobiolaging.2014.05.038. Epub 2014 Aug 27.

15.

Using longitudinal metamorphosis to examine ischemic stroke lesion dynamics on perfusion-weighted images and in relation to final outcome on T2-w images.

Rekik I, Allassonnière S, Carpenter TK, Wardlaw JM.

Neuroimage Clin. 2014 Aug 1;5:332-40. doi: 10.1016/j.nicl.2014.07.009. eCollection 2014.

16.

Structural growth trajectories and rates of change in the first 3 months of infant brain development.

Holland D, Chang L, Ernst TM, Curran M, Buchthal SD, Alicata D, Skranes J, Johansen H, Hernandez A, Yamakawa R, Kuperman JM, Dale AM.

JAMA Neurol. 2014 Oct;71(10):1266-74. doi: 10.1001/jamaneurol.2014.1638.

17.

Brain region's relative proximity as marker for Alzheimer's disease based on structural MRI.

Lillemark L, Sørensen L, Pai A, Dam EB, Nielsen M; Alzheimer's Disease Neuroimaging Initiative.

BMC Med Imaging. 2014 Jun 2;14:21. doi: 10.1186/1471-2342-14-21.

18.

Brain volume reductions in adolescent heavy drinkers.

Squeglia LM, Rinker DA, Bartsch H, Castro N, Chung Y, Dale AM, Jernigan TL, Tapert SF.

Dev Cogn Neurosci. 2014 Jul;9:117-25. doi: 10.1016/j.dcn.2014.02.005. Epub 2014 Feb 22.

19.

What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus.

Fjell AM, McEvoy L, Holland D, Dale AM, Walhovd KB; Alzheimer's Disease Neuroimaging Initiative.

Prog Neurobiol. 2014 Jun;117:20-40. doi: 10.1016/j.pneurobio.2014.02.004. Epub 2014 Feb 16. Review.

20.

Biological heterogeneity in ADNI amnestic mild cognitive impairment.

Nettiksimmons J, DeCarli C, Landau S, Beckett L; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2014 Sep;10(5):511-521.e1. doi: 10.1016/j.jalz.2013.09.003. Epub 2014 Jan 10.

Items per page

Supplemental Content

Write to the Help Desk